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Abstract
A membrane protein complex, succinate dehydrogenase (SQR) from Escherichia coli has been purified and crystallised.
This enzyme is composed of four subunits containing FAD, three iron^sulphur clusters and one haem b as prosthetic groups.
The obtained crystals belong to the hexagonal space group P63 with the unit-cell dimensions of a = b = 123.8 Aî and c = 214.6
Aî . An asymmetric unit of the crystals contains one SQR monomer (Mr 120 kDa). A data set is now available at 4.0 Aî
resolution with 88.1% completeness and 0.106 Rmerge. We have obtained a molecular replacement solution that shows sensible
molecular packing, using the soluble domain of E. coli QFR (fumarate reductase) as a search model. The packing suggests
that E. coli SQR is a crystallographic trimer rather than a dimer as observed for the E. coli QFR. ß 2002 Published by
Elsevier Science B.V.
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1. Introduction
In cells respiring under aerobic conditions with
oxygen as the terminal electron acceptor, the mem-
brane-bound enzyme succinate:ubiquinone oxidore-
ductase (SQR) is a functional member of both the
Krebs cycle and the respiratory chain. This enzyme,
also known as Complex II or succinate dehydroge-
nase, couples the oxidation of succinate to fumarate
in the cytoplasm to quinone reduction in the mem-
brane. In anaerobic respiration, where fumarate is
the terminal electron acceptor, the opposite reaction,
reduction of fumarate to succinate, is catalysed by
another enzyme, menaquinol:fumarate reductase or
QFR.
SQR and QFR are collectively referred to as suc-
cinate:quinone oxidoreductases. They can generally
catalyse both succinate oxidation and fumarate re-
duction but at di¡erent rates and have, in fact,
been shown to be able to replace each other [1].
The enzyme is composed of a large soluble domain
located on the cytoplasmic side (or matrix side in
mitochondria) of the membrane and a smaller mem-
brane anchor domain. The primary sequence of the
soluble domain is highly conserved between species
(30^50% sequence identity) and consists of a £avo-
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protein subunit (Fp subunit; 64^79 kDa) and an
iron^sulphur protein subunit (Ip subunit; 27^31
kDa). The membrane anchor domain shows much
lower sequence identity (less than 20%) and varies
in composition between organisms. It may consist
of one larger (23^30 kDa) polypeptide carrying two
protohaem IX (haem b) or two smaller (11^18 kDa)
polypeptides carrying one haem or no haem at all [2].
Structures of Wolinella succinogenes QFR (PDB
entry 1QLA) [3] and Escherichia coli QFR (PDB en-
try 1FUM) [4] have been solved at 2.2 and 3.3 Aî ,
respectively. W. succinogenes QFR has a membrane
anchor domain consisting of one polypeptide con-
taining two haem b groups while the membrane an-
chor domain of E. coli QFR consists of two poly-
peptides and contains no haem b. Although both
proteins form crystallographic dimers, the relative
orientation between monomers is di¡erent between
the enzymes. W. succinogenes QFR seems a stable
dimer with a large interface, whereas E. coli QFR
dimer is only indirectly connected through the bound
detergent molecules. Two menaquinone binding sites
have been found in the E. coli QFR structure con-
sistent with biochemical data [5], although these sites
have not been well characterised due to limited res-
olution. There is no structural information for the
quinone binding site(s) of W. succinogenes QFR.
Further studies on the membrane anchor domain,
including better characterisation of the quinone bind-
ing site(s), are necessary.
SQR from E. coli belongs to a third type of succi-
nate:quinone oxidoreductases which contains two
membrane anchor subunits, SdhC (14.2 kDa) and
SdhD (12.8 kDa), and one haem b. The membrane
anchor domain is well characterised by biochemical
studies including gene deletion and mutational anal-
ysis [6,7]. The structure of SQR from E. coli would
show not only the ¢rst structure of a one-haem con-
taining succinate:quinone oxidoreductase, but would
also be the ¢rst known SQR structure from any or-
ganism. It could help to answer questions such as
why there are two di¡erent enzymes when both
SQR and QFR can perform the same reactions and
why haem is present in E. coli SQR when both E.
coli QFR and a mutant of E. coli SQR can function
without haem [8]. Here, we report puri¢cation and
crystallisation for SQR from E. coli. We have ob-
tained a molecular replacement solution that shows
sensible molecular packing, using the soluble domain
of E. coli QFR (PDB entry 1FUM) as a search mod-
el.
2. Materials and methods
2.1. Expression
E. coli strain DW35 transformed with plasmid
pFAS (PFRDsdhCDAB) was used for growth and ex-
pression of membrane-bound SQR [1]. DW35 con-
tains a deletion of the frdABCD operon and has the
sdhCDAB operon disrupted with the result that chro-
mosomally encoded SQR or QFR are not produced
by the organism [5]. Plasmid pFAS has the complete
coding sequence for sdhCDAB under the control of
the fumarate reductase promoter (PFRD) in order
that the sdhCDAB genes can be expressed anaerobi-
cally under conditions normally used for expression
of QFR [1]. To express SQR, DW35 transformed
with pFAS was used to inoculate 150 ml of Terri¢c
broth [9] containing 150 Wg/ml ampicillin in a 1-l
£ask and grown with vigorous aeration for 6 h.
The 150-ml culture was then used to inoculate 1.2 l
of Terri¢c broth with ampicillin in a 2-l £ask and the
cell culture was grown with moderate aeration (200
rpm in a New Brunswick G25 rotary shaker) for 18 h
at 310 K before harvesting by centrifugation (15 min
at 6000Ug). The cells from six £asks prepared as
described above (typically 30^40 g wet weight) were
immediately resuspended in 150^200 ml of 0.1 M
potassium phosphate bu¡er (pH 6.8) with 0.1 mM
EDTA and three Complete protease inhibitor tablets
(Roche, Indianapolis, Indiana). All subsequent steps
were done at 278 K. The cells were then disrupted by
two passages through an EmulsiFlex C5 homogenis-
er (Avestin, Ottawa, Canada) at 15 000 psi. The ho-
mogenate was then subjected to a low-speed centri-
fugation (3000Ug for 10 min) to remove unbroken
cells. The supernatant was then carefully decanted
and the membrane fraction was isolated following
centrifugation at 120 000Ug in a Beckman Ti60 ro-
tor for 45 min. The supernatant containing the cyto-
plasmic fraction was discarded and the intense red-
dish-brown membrane fraction was then stored at
203 K until used for puri¢cation of the SQR com-
plex.
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The membrane fraction prepared from six £asks as
described above contains approximately 800 mg of
total protein. Due to the high level of expression
from pFAS at this stage the membranes contain
approximately 25^35% of their protein content as
SQR.
2.2. Solubilisation and puri¢cation
The procedure for solubilisation and puri¢cation
of SQR is a modi¢cation of that previously used to
prepare crystallisation quality E. coli QFR [10]. The
membranes (approximately 800 mg total protein) en-
riched with SQR were resuspended with a Te£on-
glass homogeniser in 120 ml of bu¡er A (20 mM
Tris^HCl, 0.2 mM EDTA, pH 7.4) with three Com-
plete protease inhibitor tablets. The detergent Thesit
(polyoxyethylene(9)dodecyl ether, C12E9) (Roche, In-
dianapolis, IN) was added from a 20% (w/v) stock
solution to give a ¢nal concentration of 2%. The
suspension was then stirred brie£y (5 min at 278
K) and then sedimented by centrifugation at
100 000Ug for 30 min. The intense reddish-brown
supernatant was ¢ltered through a 0.2-Wm nylon ¢l-
ter before chromatography.
The reddish-brown extract was then immediately
loaded onto a DEAE-Sepharose FF column (3.6U20
cm, 200-ml bed volume, Amersham-Pharmacia Bio-
tech, Sweden) attached to an Aº KTA explorer puri¢-
cation system equilibrated with bu¡er B (20 mM
Tris^HCl, 0.2 mM EDTA, and 0.05% Thesit, pH
7.4). The column was washed with 2-bed volumes
of bu¡er B, followed by 2-bed volumes of bu¡er B
containing 0.1 M NaCl. The enzyme was then eluted
with a linear gradient from 0.1 to 0.3 M NaCl in
bu¡er B at a £ow rate of 1^1.5 ml/min. Fractions
of 20 ml in size were collected and the brownish-
red fractions with the highest ratio of 412/350 nm
to 280 nm absorbance and the highest SQR enzyme
activity were pooled. SQR elutes as a broad peak at
about 0.25 M NaCl during the gradient. The pooled
fractions are then concentrated to approximately 10
ml using a Amicon YM30 stirred cell under nitrogen.
The concentrated SQR containing fractions were
then further puri¢ed using perfusion chromatogra-
phy. Before loading onto a Poros 50HQ (1.6U10
cm) column, the enzyme is diluted to 50 ml with
bu¡er A. The enzyme was then eluted using an iden-
tical chromatographic strategy as was used with the
DEAE-Sepharose FF column. The £ow rate was
3 ml/min and fractions of 10 ml in size were col-
lected. The reddish-brown fractions containing SQR
were then combined, concentrated as above, and
loaded onto a Sephacryl S-300 gel ¢ltration column
(2.6U60 cm). This column was previously equilibrat-
ed with bu¡er C (20 mM Tris^HCl and 0.05% The-
sit, pH 7.4). The £ow rate for the column was 0.2 ml/
min and 5-ml fractions were collected. The central
protein peak eluting from this column contains the
highly puri¢ed and crystallisation quality SQR. The
fractions from this central peak were pooled, concen-
trated as above, ¢ltered with a 0.2-Wm nylon ¢lter
and ¢nally concentrated with sterile Centriprep-30
concentrators (Amicon, Beverly, MA) to a ¢nal pro-
tein concentration of 50^60 mg protein/ml. The en-
zyme was then immediately used for crystallisation
trials or stored at 203 K for later use.
2.3. Crystallisation
Prior to crystallisation, the protein sample bu¡er
was changed to a bu¡er containing 20 mM MOPS
(pH 7.4) and 0.1% Thesit using a Superdex 200 Gel-
¢ltration column (Amersham-Pharmacia Biotech), at
a £ow rate of 0.5 ml/min. The fractions containing
Fig. 1. Crystal of E. coli SQR. The dimensions of the crystal
are 0.2U0.2U0.05 mm3.
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SQR were pooled and concentrated in a Centricon
100 cell (Amicon, cut-o¡ 100 kDa) to 20^25 mg pro-
tein/ml. Crystals were obtained by the hanging-drop
vapour-di¡usion technique. The protein solution was
mixed in a 1:1 ratio with the reservoir solution,
which only contained 4 M sodium formate, and left
to equilibrate at 283 K.
2.4. Data collection, processing and molecular
replacement
X-ray data were collected from frozen crystals at
100 K. Prior to freezing, the crystals were soaked in
a freezing solution containing 20 mM MOPS (pH
7.4), 0.1% Thesit, 4.5 M sodium formate and 20%
(v/v) glycerol. Three data sets were collected on three
di¡erent crystals at the ESRF at beamlines ID14/
EH3 and ID29. Image data were processed using
the HKL program suite [11] and the CCP4 program
suite [12]. Molecular replacement was performed us-
ing the program AMoRe [13].
3. Results and discussion
The enzyme obtained is highly active with a succi-
nate-quinone reductase kcat at 303 K in the range of
90^100 s31 using the Q1 homologue of ubiquinone as
previously described [11]. The kinetic properties and
sensitivity to inhibitors are identical to that previ-
ously described for a somewhat less pure enzyme
[14]. The extra gel-¢ltration step for bu¡er exchange
was necessary in order to obtain reproducible crys-
tals from the frozen sample. Using this ¢ltered sam-
ple crystals with a round plate shape grew within a
few weeks with average dimensions of 0.2U0.2U0.05
mm3 (Fig. 1).
Crystals di¡racted X-rays to around 3.5 Aî (Fig. 2).
They belong to the hexagonal space group P63 with
the cell dimensions of a = b = 123.8 Aî and c = 214.6
Aî . The data sets were merged and processed to 4.0
Table 1
Data collection statistics
Resolutiona 40^4 Aî (4.14^4.00 Aî )
Wavelength 0.934
Total no. of observations 46435
Unique re£ections 13946
Redundancy 3.3
I/c(I) 7.5
I/c(I) cut-o¡ 33.0
Completenessa 88.1% (80.5%)
Ra;bmerge 0.106 (0.602)
aStatistics for highest resolution shell are given in parentheses.
bRmerge =4h4iMIi(h)3GI(h)fM/4h4i(h), where Ii(h) is the ith mea-
surement.
Fig. 2. A typical di¡raction pattern from an E. coli SQR crys-
tal. (A) The overall di¡raction pattern. (B) A close-up of the
outer di¡raction limit, typically around 3.5 Aî .
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Aî . Data collection statistics are summarised in Table
1. Due to radiation damage and anisotropy of the
crystals, it was impossible to complete the data up to
the maximum resolution limit of the crystals. Assum-
ing one SQR monomer in the asymmetric unit, the
calculated Vm [15] of the crystals is 3.7 Aî 3/Da, which
corresponds to a solvent content of 63.6%. The high
solvent content is common for membrane protein
complexes due to the detergent micelle surrounding
the proteins [16^18].
A molecular replacement study was performed us-
ing the soluble domain of QFR from E. coli as a
search model (40% and 36% sequence identity for
Fp (SdhA) and Ip (SdhB) subunits, respectively).
The membrane anchor domain was excluded from
the search model due to the lack of sequence identity
Fig. 3. The crystal packing of SQR from E. coli. The molecules were drawn using the program Molscript [20]. (A) Stereo view of the
crystal packing showing the stacking of layers of model trimers. The soluble domain of QFR is shown in the darker shade and the
membrane anchor domain in the lighter shade. The membrane anchor domain of QFR, which was not included in the search model,
is positioned relative to the soluble domains based on the QFR structure to show the approximate position of this domain. (B) The
crystal packing as seen from the top showing contacts between soluble domains.
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to SQR (17^18%). Using the program AMoRe [13]
with the data in a resolution range of 15^5 Aî , one
clear solution, with the correlation coe⁄cient of
55.4% and R-factor of 49.7%, was obtained. The
correlation coe⁄cient and R-factor for the next
best solution were 45.8 and 53.3%, respectively.
The crystal packing was checked using the pro-
gram O [19] and seemed reasonable as there is no
overlap between molecules (Fig. 3). In Fig. 3, the
membrane anchor domain of E. coli QFR, which
was not included in the search model, is positioned
relative to the soluble domains based on the QFR
structure to show the approximate position of this
domain. The ¢tted E. coli QFR model of the mem-
brane anchor domain does not ¢t the electron den-
sity very well and careful remodelling is necessary
before any further information is obtained regarding
this domain. The crystal is, in principle, a stacked
two-dimensional crystal. The packing of the trimer
is very tight and direct contact between membrane
anchor domains of monomers is observed. These
strongly suggest that the E. coli SQR forms a crys-
tallographic trimer and not a dimer as observed for
the E. coli QFR. However, it is still not clear if this
indicates any signi¢cant di¡erence of the tertiary
structure of SQR subunits from those of QFRs. In
an attempt to answer all these questions, remodelling
and re¢nement of the membrane anchor domain,
along with further optimisation of the crystallisation
conditions, are currently in progress.
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